William Jacob Savage sold $1.4M of Disc Medicine stock
By AlphaYouPublished Form 4
Savage William Jacob
Reporting filer
William Jacob Savage reported selling 16,035 shares of Disc Medicine, Inc. for about $1.4M ($85.09 a share on average). Form 4 filed Nov 12, 2026 lists 1 entry.
See the price move since this trade →
- Disclosed
- Nov 12, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Savage William Jacob | 2026-11-10 | S | Sale | 16035 | 85.0912 | 63,445 | 2 days | Filed terms
|
Common Stock
- Owner
- Savage William Jacob
- Date
- 2026-11-10
- Code
- S
- Action
- Sale
- Quantity
- 16035
- Price
- 85.0912
- Following holdings
- 63,445
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-11-10
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: false
- id: F1
- transaction Shares: 16035
- transaction Price Per Share: 85.0912
- id: F2
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 63445
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Savage William Jacob: Chief Medical Officer.
- The filing reports a Rule 10b5-1 trading plan.
- F1: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on April 10, 2026.
- F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.00 to $85.38, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4.
Original sources
Prepared automatically from public filing data. Report a correction.